Skip to main content
OpenTrials

Clinical trial condition

Lysosomal Storage Diseases, Nervous System

Explore clinical trials studying Lysosomal Storage Diseases, Nervous System. Study availability and eligibility vary by location and protocol.

513 public trials 105 recruiting studies
Refine in advanced search Browse all conditions

Lysosomal Storage Diseases, Nervous System trial results

Completed

Open Label Extension Study of 1 mg/kg Pegunigalsidase Alfa Every 2 Weeks in Patients With Fabry Disease

NCT03566017

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +29 more
Locations
  • UAB Medicine Birmingham, Alabama, United States
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • University of California San Diego La Jolla, California, United States
  • University of California Irvine Center Orange, California, United States
View all 30 locations
View Trial Details
Completed

Early Detection of Fabry Disease

NCT05106764

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
Locations
  • Universitätsklinikum Erlangen Kinder- und Jugendklinik Erlangen, Germany
  • Universitätsklinikum Erlangen Neurologische Klinik Erlangen, Germany
  • Universitätsklinikum Giessen Giessen, Germany
View Trial Details
Completed

A Study to Assess the Long-term Safety and Efficacy of ATB200/AT2221 in Adult Subjects With Late-Onset Pompe Disease (LOPD)

NCT04138277

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +13 more
Locations
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • University of California, Irvine Irvine, California, United States
  • University of Florida Clinical Research Center Gainesville, Florida, United States
  • Emory Clinic Atlanta, Georgia, United States
View all 60 locations
View Trial Details
Completed

PREDIGA 2: Spanish Acronym of "Educational and Diagnostic Project for Gaucher and ASMD"

NCT05641103

Conditions
ASMD, Acid Sphingomyelinase Deficiency, Brain Diseases, +25 more
Locations
  • Hospital General Universitario de Alicante Alicante, Spain
  • Hospital de Poniente El Ejido, Almería, Spain
  • Hospital Universitario de Badajoz Badajoz, Spain
  • Hospital Vall d'Hebron Barcelona, Spain
View all 14 locations
View Trial Details
Completed

Switch Over Study of Biosimilar Agalsidase Beta for Fabry Disease

NCT05843916

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
Locations
  • Instituto de Nefrología Pergamino S.R.L Pergamino, Buenos Aires, Argentina
  • Centro Médico Santa María de la Salud San Isidro, Buenos Aires, Argentina
  • Instituto de Investigaciones Clínicas Quilmes Buenos Aires, Argentina
  • Clínica Universitaria Reina Fabiola Córdoba, Argentina
View Trial Details

Related conditions